Telehealth companies marketing or selling compounded products should verify : Overview of the CPOM Allegations Against Mochi Health and Fella Health Two complaints were filed by Eli Lilly against telehealth companies on April 23, 2025: Mochi Health and Fella Health operate similar telehealth companies that market or sell compounded versions of Eli Lillys GLP-1 drugs, and the Mochi Health Complaint and the Fella Health Complaint contain similar facts and allegations
Rybelsus (tablet) is employed to reduce blood sugar levels for type 2 diabetic patients along with diet and exercise and is given as a tablet once a day
The 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults classifies hypertension, or high blood pressure, as having top and bottom blood pressure measures greater than or equal to 130/80 mm Hg
Reconstitution is not merely about adding liquid to a powder
Other data show that 17.7% of semaglutide users regain all the weight they lost or more after discontinuation
Semaglutide is meant to be a long-term treatment, but it is not indefinite